Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Complement-fixing antigen of human sarcomas

J Sethi, Y Hirshaut

Journal of the National Cancer Institute

|September 1, 1976

Summary

This summary is machine-generated.

Researchers identified a sarcoma-associated antigen, S3, detected via complement fixation. Antibody levels to S3 increased after tumor removal and were common in various cancers, suggesting broader immune implications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pastors' perceptions of faith-based cancer prevention/early detection programs in Virginia: a mixed methods study.

Health education research·2026

Same author

Adult IgA vasculitis-look for triggers.

QJM : monthly journal of the Association of Physicians·2023

Same author

Peripartum thrombotic microangiopathy-a enigma.

QJM : monthly journal of the Association of Physicians·2023

Same author

Thrombotic microangiopathy in Russel's viper envenomation.

QJM : monthly journal of the Association of Physicians·2022

Same author

Superallowed α Decay to Doubly Magic ^{100}Sn.

Physical review letters·2018

Same author

Time to Revisit the Use of Nontunneled Dialysis Vascular Catheters Even in Cost-Limited Setting.

Indian journal of nephrology·2018

Same journal

Response to Wang et al. and Shen et al.

Journal of the National Cancer Institute·2026

Same journal

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal of the National Cancer Institute·2026

Same journal

Beyond R2: Assessing quality of trial level surrogate endpoints in colorectal cancer.

Journal of the National Cancer Institute·2026

Same journal

A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

Journal of the National Cancer Institute·2026

Same journal

Response to Yu, Wang and Ge.

Journal of the National Cancer Institute·2026

Same journal

Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

Journal of the National Cancer Institute·2026

See all related articles

Area of Science:

Immunology
Oncology

Background:

Humoral immune responses in sarcoma patients are complex.
Tumor-associated antigens play a role in cancer immunity.

Purpose of the Study:

To investigate sarcoma-associated antigens and patient immune responses.
To characterize a specific antigen, S3, and its antibody prevalence.

Main Methods:

Complement fixation assays were used.
Analysis of circulating antibody levels in sarcoma patients before and after tumor resection.
Prevalence study of antibodies in patients with various malignancies.

Main Results:

A sarcoma-associated antigen, S3, was identified and detected by complement fixation.

Related Experiment Videos

Circulating antibody levels to S3 significantly increased post-surgical tumor removal.

Antibodies to S3 were prevalent in patients with non-sarcoma malignant tumors.

Conclusions:

S3 is a relevant sarcoma-associated antigen.
Humoral immune response to S3 is detectable and dynamic after tumor resection.
The prevalence of S3 antibodies suggests potential cross-reactivity or shared antigens in various cancers.